Related Experiment Videos
[Medical therapy for menstrual migraine]
1Neurologe, Leopoldstrasse 59/II, D-80 802 München.
Schmerz (Berlin, Germany)
|June 17, 1996
Summary
Menstrual migraines affect 7-10% of women and occur around periods. Treatment varies by duration, with short attacks managed by specific medications and longer ones potentially needing short-term prophylaxis.
Area of Science:
- Neurology
- Gynecology
Context:
- Menstrual migraine affects 7-10% of women, occurring around their menstrual period.
- Treatment strategies are duration-dependent, ranging from 3 to 7 days per attack.
Purpose:
- To outline effective treatment and prophylaxis strategies for menstrual migraine.
- To clarify which treatments are obsolete for menstrual migraine.
Summary:
- Short-duration attacks (up to 3 days) benefit from acetylsalicylic acid, ergotamine tartrate, or naproxen combined with an antiemetic.
- For persistent attacks (>3 days), short-term prophylaxis with naproxen or estrogen patches is recommended.
- Sumatriptan is an option if initial treatments fail; ovulation inhibitors and traditional migraine prophylaxis are ineffective.
Impact:
- Provides clear, evidence-based guidelines for managing menstrual migraine.
- Highlights the obsolescence of certain treatments like tamoxifen for menstrual migraine.
- Emphasizes the importance of headache diaries for patient management.